Health & Veritas

Howie and Harlan discuss the state of the omicron surge and what we know and don’t know about the variant. Then they’re joined by Yale scientist Anne Wyllie, whose new research casts doubt on the ability of rapid antigen tests to detect asymptomatic omicron infections.

Howie and Harlan are joined by Dr. Albert Ko, a Yale epidemiologist who has advised Connecticut governor Ned Lamont. They discuss the state of the pandemic, rebuilding global public health infrastructure, and what omicron tells us about future variants.

Howie and Harlan are joined by Yale economist Fiona Scott Morton, an expert on competition in healthcare and other industries. They discuss the forces driving up healthcare costs in the U.S. and the steps that Scott Morton and her colleagues have proposed to bring them under control.

Howie and Harlan are joined by Liza Fisher to talk about her experience navigating the medical system and advocating for patients while enduring 18 months of debilitating COVID symptoms. Fisher is a participant and co-author (with Harlan) for a new study examining internal tremors and vibrations among long COVID patients. 

Howie and Harlan discuss what we know and don’t know about the newly identified omicron variant. Then they’re joined by Dr. Joseph Ross to discuss the strengths and weaknesses of the FDA’s process for approving new drugs.

Howie and Harlan talk with Dr. Rohan Khera, a Yale cardiologist whose research interests include the use of advanced data science tools to improve diagnosis and treatment. They discuss how artificial intelligence and machine learning can supplement human expertise in summarizing current literature, interpreting electrocardiograms, and other areas.

Howie and Harlan are joined by Jason Abaluck, a health economist at the Yale School of Management. They discuss a massive study co-authored by Abaluck that showed that masks reduce COVID infections in a community setting.

Howie and Harlan are joined by Anne Wyllie, the Yale scientist who developed the SalivaDirect test for COVID-19. They discuss the development of the technology and its potential for enabling easier testing in a variety of communities.

Howie and Harlan are joined by Dr. Mary-Ann Etiebet, who leads Merck for Mothers and Merck's health equity efforts. They discuss the factors that lead to preventable death during pregnancy and childbirth—a risk that disproportionately affects women of color. 

Howie and Harlan are joined by Elizabeth Bradley, an expert on global public health and the president of Vassar College. They discuss how the residential liberal arts college navigated the pandemic—and how defining a set of core values helped guide its response.